Search results for "stroke."

showing 10 items of 1178 documents

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multi…

2017

Supplemental Digital Content is available in the text

Blood GlucoseMalerheumatoid arthritisCross-sectional studyType 2 diabetesTriglycerideArthritis Rheumatoid0302 clinical medicineRisk FactorsCardiovascular DiseasePrevalence030212 general & internal medicineMyocardial infarctionStrokeSubclinical infectionAged 80 and overMetabolic SyndromeMetabolic Syndrome XGeneral MedicineMiddle Agedinflammatory processCholesterolItalyCardiovascular DiseasesRheumatoid arthritisAtherosclerosiHypertensionComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFemaleHumanResearch ArticleAdultmedicine.medical_specialtyAdolescentsubclinical atherosclerosisObservational Study03 medical and health sciencesYoung Adultcardiovascular eventsInternal medicinemedicineHumansTriglyceridesAged030203 arthritis & rheumatologyCross-Sectional Studiebusiness.industryRisk Factor6900medicine.diseaseAtherosclerosisCross-Sectional StudiesDiabetes Mellitus Type 2Physical therapyMetabolic syndromebusinessRheumatismtraditional cardiovascular risk factorMedicine
researchProduct

Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention.

2017

In patients with stable coronary artery disease, clinical outcomes are predominantly characterized by the consequences of atherosclerosis on the myocardium, but also by complications of atherosclerosis, notably recurrent acute coronary syndrome or stroke. Secondary prevention therapy is therefore key in this patient population. Intensification of secondary prevention therapy is possible, at the price of a therapeutic risk or a high cost, therefore justifying careful selection of patients with a high residual risk and low therapeutic risk. Two lines of therapy can be intensified, independently of each other, namely anti-thrombotics and lipid-lowering agents. Intensification of anti-thromboti…

Blood Plateletsmedicine.medical_specialtyAcute coronary syndromeStatinEpidemiologymedicine.drug_classCoronary Artery Disease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineEzetimibeFibrinolytic AgentsRecurrenceRisk FactorsInternal medicineDiabetes mellitusmedicineSecondary PreventionHumans030212 general & internal medicineMyocardial infarctionStrokeBlood CoagulationDyslipidemiasHypolipidemic Agentsbusiness.industryPatient Selectionmedicine.diseaseLipidsResidual riskTreatment OutcomeDisease ProgressionCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugEuropean journal of preventive cardiology
researchProduct

Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats

2011

Mildronate (3-(2,2,2-trimethylhydrazinium) propionate) is an inhibitor of l-carnitine biosynthesis and an anti-ischemic drug. In the present study, we investigated the effects of mildronate in rats following focal cerebral ischemia. Male Wistar rats were subjected to transient occlusion of the middle cerebral artery (MCAO) for 90min, followed by the intraperitoneal administration of mildronate at doses of 100 and 200mg/kg 2h after reperfusion and then daily for an additional 14days. The beam-walking, rota-rod and cylinder tests were used to assess sensorimotor function, and vibrissae-evoked forelimb-placing and limb-placing tests examined responses to tactile and proprioceptive stimulation.…

Brain InfarctionMaleIschemiaStimulationPharmacologyRotarod performance testBrain ischemiaBehavioral NeuroscienceAdjuvants ImmunologicTandem Mass SpectrometryCarnitinemedicine.arterymedicineAnimalsRats WistarStrokeChromatography High Pressure LiquidAnalysis of VarianceDose-Response Relationship Drugbusiness.industryExtremitiesInfarction Middle Cerebral ArteryRecovery of Functionmedicine.diseaseRatsBetaineDose–response relationshipRotarod Performance TestVibrissaeMiddle cerebral arterySystemic administrationbusinessNeuroscienceLocomotionPsychomotor PerformanceMethylhydrazinesBehavioural Brain Research
researchProduct

Flat Panel Computed Tomography Pooled Blood Volume and Infarct Prediction in Endovascular Stroke Treatment

2019

Background and Purpose— Patients with large-vessel stroke frequently need to be transferred to comprehensive stroke centers for endovascular treatment. An update of physiological perfusion parameters and stroke progression on arrival is desirable. We examined the reliability of preinterventional pooled blood volume (PBV)-maps acquired by flat-panel detector computed tomography (CT) in the interventional angiography suite. Methods— The volumes of preinterventional perfusion deficit in flat-panel detector CT-PBV source images were compared with final infarct volume on follow-up multislice-CT after endovascular treatment of 29 consecutive patients with occlusion of the middle cerebral artery …

Brain InfarctionMaleMechanical Thrombolysismedicine.medical_treatmentBlood volume030204 cardiovascular system & hematology03 medical and health sciencesPostoperative Complications0302 clinical medicinePredictive Value of Testsmedicine.arteryOcclusionmedicineCerebral Blood VolumeHumanscardiovascular diseasesStrokeAgedAdvanced and Specialized Nursingmedicine.diagnostic_testbusiness.industryCerebral infarctionEndovascular ProceduresThrombolysisMiddle Agedmedicine.diseaseCerebral AngiographyStrokeMiddle cerebral arteryAngiographyFemaleNeurology (clinical)Internal carotid arteryTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessNuclear medicine030217 neurology & neurosurgeryFollow-Up StudiesStroke
researchProduct

Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma

2005

Thrombosis is the most frequent complication and the second cause of death in patients with malignant disease. Primary central nervous system non-Hodgkin's lymphoma represents a rare pathology. Resistance to APC is usually linked to a factor V (FV) gene mutation changing an Arg 506 to a Gln in the APC cleavage site.In our study, we aimed at investigating the presence of activated protein C resistance (APC-r) and other markers of hypercoagulability in 25 selected patients with a diagnosis of primitive cerebral lymphoma who had suffered from an ischemic episode of TIA and/or stroke.25 selected patients with a diagnosis of primitive cerebral lymphoma and 50 healthy subjects acted as control gr…

Brain NeoplasmsLymphoma Non-HodgkinFactor VPeptide FragmentsBrain NeoplasmStrokePhenotypePeptide FragmentIschemic Attack TransientCase-Control StudiesMutationPlasminogen Activator Inhibitor 1HumansProthrombinCase-Control StudieBlood CoagulationBiomarkersHumanActivated Protein C Resistance
researchProduct

2015

The recombinant form of tissue plasminogen activator (rt-PA) is the only curative treatment for ischemic stroke. Recently, t-PA has been linked to the metabolism of brain-derived neurotrophic factor (BDNF), a major neurotrophin involved in post-stroke neuroplasticity. Thus, the objective of our study was to investigate the impact of rt-PA treatment on post-stroke circulating BDNF levels in humans and in animals. Serum BDNF levels and t-PA/plasmin activity were measured at hospital admission and at up to 90 days in stroke patients receiving (n = 24) or not (n = 14) rt-PA perfusion. We investigated the relationships between serum BDNF with concurrent t-PA/plasmin activity, neurological outcom…

Brain-derived neurotrophic factor0303 health sciencesmedicine.medical_specialtyPathologyMultidisciplinaryPlasminbusiness.industrymedicine.diseaseTissue plasminogen activator3. Good healthBrain ischemia03 medical and health sciences0302 clinical medicineEndocrinologyBlood pressurenervous systemInternal medicinemedicineEndothelial dysfunctionbusinessStroke030217 neurology & neurosurgeryFibrinolytic agent030304 developmental biologymedicine.drugPLOS ONE
researchProduct

Development and validation of the neighborhood environment walkability scale for youth across six continents

2019

Abstract Background The IPEN International Physical Activity and Environment Network Adolescent project was conducted using common study protocols to document the strength, shape, and generalizability of associations of perceived neighborhood environment attributes with adolescents’ physical activity and overweight/obesity using data from 15 countries. Countries did not use identical versions of the Neighborhood Environment Walkability Scale for Youth (NEWS-Y) to measure perceived neighborhood environment attributes. Therefore, this study derived a measurement model for NEWS-Y items common to all IPEN Adolescent countries and developed a scoring protocol for the IPEN Adolescent version of t…

Built environmentHealth BehaviorMedicine (miscellaneous)WalkingCardiovascularAdolescentsMedical and Health SciencesACCESSIBILITYDevelopmental psychology0302 clinical medicineResidence CharacteristicsSurveys and QuestionnairesMedicine and Health SciencesSOCIOECONOMIC-STATUS030212 general & internal medicinelcsh:RC620-627Built environmentPediatricNutrition and Dieteticslcsh:Public aspects of medicineIPEN ADULTGlobal16. Peace & justiceConfirmatory factor analysisStrokelcsh:Nutritional diseases. Deficiency diseasesWalkabilityScale (social sciences)HEALTH OUTCOMESRELIABILITYPublic Health0305 other medical sciencePsychologyBEHAVIORPediatric Research InitiativeAdolescentPARTICIPATIONeducationPhysical Therapy Sports Therapy and RehabilitationPooled analysesConfirmatory factor analysisEducation03 medical and health sciencesClinical ResearchBehavioral and Social ScienceMEASURED PHYSICAL-ACTIVITYHumansGeneralizability theoryObesityCategorical variableSocioeconomic statusExercise030505 public healthQuestionnairePreventionMethodologyConstruct validityReproducibility of Resultslcsh:RA1-1270social sciencesAdolescent BehaviorInternational Journal of Behavioral Nutrition and Physical Activity
researchProduct

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strat…

2021

Abstract Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerides (TG), TG-rich lipoproteins (TRL), and TRL remnants, and increased risk of myocardial infarction, ischaemic stroke, and aortic valve stenosis. These data also indicate that TRL and their remnants may contribute significantly to residual cardiovascular risk in patients on optimized low-density lipoprotein (LDL)-lowering therapy. This statement critically appraises current understanding of the structure, function, and metabolism of TRL, and their pathophysiological role in atherosclerotic cardiova…

CHOLESTERYL ESTER TRANSFERTO-MODERATE HYPERTRIGLYCERIDEMIALipoprotein remnants030204 cardiovascular system & hematologyBioinformaticsResidual riskBrain Ischemiachemistry.chemical_compoundVoeding Metabolisme en Genomica0302 clinical medicineIschaemic strokeAcademicSubjects/MED00200Myocardial infarctionLOW-GRADE INFLAMMATIONALL-CAUSE MORTALITY[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism0303 health sciencesAtherosclerotic cardiovascular diseasedigestive oral and skin physiology[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismCardiovascular diseaseMetabolism and Genomics3. Good healthStrokeLOW-DENSITY LIPOPROTEINSCardiovascular DiseasesMetabolisme en GenomicaCORONARY-ARTERY-DISEASENutrition Metabolism and GenomicsCardiology and Cardiovascular MedicineB-CONTAINING LIPOPROTEINSLipoproteinsTriglyceride-rich lipoproteinsHEART-DISEASE03 medical and health sciencesSpecial ArticleVoedingmedicineHumansHOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIATriglycerides030304 developmental biologyNutritionVLAGTriglyceridebusiness.industryAPO-Bmedicine.diseaseAtherosclerosisResidual riskIncreased riskchemistry3121 General medicine internal medicine and other clinical medicineEuropean atherosclerosis societybusinessLipoprotein
researchProduct

Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: One-Year Follow-up

2023

Background and objectives: Declines in stroke admission, intravenous thrombolysis, and mechanical thrombectomy volumes were reported during the first wave of the COVID-19 pandemic. There is a paucity of data on the longer-term effect of the pandemic on stroke volumes over the course of a year and through the second wave of the pandemic. We sought to measure the impact of the COVID-19 pandemic on the volumes of stroke admissions, intracranial hemorrhage (ICH), intravenous thrombolysis (IVT), and mechanical thrombectomy over a one-year period at the onset of the pandemic (March 1, 2020, to February 28, 2021) compared with the immediately preceding year (March 1, 2019, to February 29, 2020). M…

COVID-19; acute stroke; intracranial hemorrhage; intravenous thrombolysis; ischemic stroke; mechanical thrombectomyNeurology
researchProduct

Energy compensation and adiposity in humans

2021

Publisher Copyright: © 2021 The Authors Understanding the impacts of activity on energy balance is crucial. Increasing levels of activity may bring diminishing returns in energy expenditure because of compensatory responses in non-activity energy expenditures.1–3 This suggestion has profound implications for both the evolution of metabolism and human health. It implies that a long-term increase in activity does not directly translate into an increase in total energy expenditure (TEE) because other components of TEE may decrease in response—energy compensation. We used the largest dataset compiled on adult TEE and basal energy expenditure (BEE) (n = 1,754) of people living normal lives to fi…

Calorie030309 nutrition & dieteticsEnergy balanceRA773SDG 3 – Goede gezondheid en welzijnCardiovascularMedical and Health SciencesOral and gastrointestinalCompensation (engineering)RC12000302 clinical medicineWeight lossenergy compensationAdiposityCancer0303 health sciencesexerciseCONSTRAINTBiological SciencesStrokeIAEA DLW database groupEXERCISE PHYSICAL-ACTIVITYmedicine.symptomGeneral Agricultural and Biological SciencesINTERVENTIONSEnergy (esotericism)WEIGHT-LOSS030209 endocrinology & metabolismMASSBiologyArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesAffordable and Clean EnergySDG 3 - Good Health and Well-beingTotal energy expenditureClinical Researchdaily energy expendituremedicineVDP::Matematikk og Naturvitenskap: 400::Basale biofag: 470HumansBASALObesityMetabolic and endocrineenergy management modelsNutritionHomo sapiensBIRDSactivityPsychology and Cognitive Sciencesmedicine.diseaseObesitytrade-offsMETABOLIC-RATESBasal metabolic ratebasal metabolic rate1182 Biochemistry cell and molecular biologyDemographic economics3111 Biomedicineweight lossEnergy MetabolismEnergy IntakeEXPENDITUREDevelopmental Biology
researchProduct